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Abstract
DNA microarray technology is a high-throughput method for gaining information on
gene function. Microarray technology is based on deposition/synthesis, in an ordered
manner, on a solid surface, of thousands of EST sequences/genes/oligonucleotides.
Due to the high number of generated datapoints, computational tools are essential in
microarray data analysis and mining to grasp knowledge from experimental results.
In this review, we will focus on some of the methodologies actually available to deﬁne
gene expression intensity measures, microarray data normalization, and statistical
validation of differential expression. Copyright  2003 John Wiley & Sons, Ltd.
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Introduction
Microarrays can be a valuable tool for deﬁning
transcriptional signatures bound to a pathological
condition, or to rule out molecular mechanisms
tightly bound to transcription. However, because
our current knowledge of gene function in higher
eukaryotes is still limited, microarray analysis
frequently does not imply a ﬁnal answer to a
biological problem, but allows the discovery of new
research paths that allow us to explore it from a
different perspective. Additionally, it is essential
to point out that a gold standard methodology
to identify, with high sensitivity and precision,
‘biologically meaningful’ differential expression of
genes is not yet available. Therefore, it is important
to explore data by multiple approaches in order to
generate a robust set of results [14].
Microarray technology was initially developed
by Schena and co-workers [15] and it is based on
spotting, in an ordered manner, on a solid surface,
of thousands of EST sequences/genes. Microarrays
have also been developed using photolithographic
oligonucleotide synthesis (Affymetrix, Santa Clara,
CA). cDNA spotted arrays are characterized by the
use of one long stretch of bases for each gene,
whereas in Affymetrix GeneChips up to 20 short
oligonucleotides (probe set) are used to probe each
gene/EST. Although Affymetrix arrays are far from
being the ultimate solution for the characterization
of gene expression they are, so far, one of the most
used commercially available platforms for genome-
wide transcriptional proﬁling analyses.
In this review, we will focus on computational
approaches for GeneChip expression measures,
data normalization and statistical validation.
The Affymetrix GeneChip
To assess the target hybridization speciﬁcity of each
oligo (PM: perfect match) of the probe set, a ‘neg-
ative control’ oligonucleotide (MM: mismatch) is
associated to each PM. This oligonucleotide has a
sequence equal to PM but with a single central mis-
match, which strongly destabilizes the hybridiza-
tion of the target; the couple PM/MM is called a
probe pair (the number, j, of probe pairs in a probe
set ranges between 12 to 20). Consequently, eval-
uation of the hybridization signals on PM and MM
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probes gives an indication of the aptitude of any
PM to identify a speciﬁc target, as a strong sig-
nal in the MM probe is a warning of the presence
of cross-hybridizing targets. Target hybridization
to Affymetrix GeneChips allows the generation
of absolute intensity values describing the mRNA
expression level. Therefore, to generate a ‘virtual
two-dye’ experiment, two GeneChips have to be
used.
Probe set intensity signal calculation
To deﬁne a measure of expression representing
the amount of the corresponding mRNA species
it is necessary to summarize probe intensities for
each probe set. Several model-based approaches
to this problem have been proposed: the model-
based expression index (MBEI [10]), the MAS 5.0
statistical algorithm from Affymetrix [1] and the
robust multi chip average (RMA [7]).
Affymetrix MAS software [1] computes the
probe set intensity signal as the anti-log of a
robust average (Turkey biweight) of the values
log(PMij − CTij). CT is deﬁned as a quantity
equal to MM when MM < PM, but adjusted to
be less than PM when MM ≥ PM, which is a
quite frequent event [8]. A model for MAS 5.0
probe set intensity measures is log(PMij − CTij) =
log(θi) + εij,j = 1,...,J. The expression quantity
on array i is represented by θi and εij is the error
term which is equal to the variance for j = 1,...,J.
Furthermore, MAS 5.0 assigns to each probe set an
expression call (i.e. call P, gene is expressed; call
A, gene is not expressed; call M, gene is marginally
expressed).
The dCHIP software [10] computes the probe
set intensity signal using a multiplicative model:
PMij − MMij = θiφj + εij,i = 1,...,I ,j = 1,...,
J. This model is based on the observation that the
variation of a speciﬁc probe across multiple arrays
could be considerably smaller than the variance
across probes within a probe set [11], which
indicates a strong probe afﬁnity effect (φj). φj can
be calculated by dCHIP if a sufﬁcient number
of arrays (8–10) are available for the analysis.
Fitting the model ‘dCHIP expression measures’ are
obtained for each probe set. Furthermore, dCHIP
allows the assessment of a standard error (SE)
for each probe set intensity measure, which is an
indicator of the hybridization quality to the probe
set. SEs are useful for discarding probe sets with
low hybridization quality.
The RMA expression measure (log scale Robust
Multi-array Analysis), implemented in Affymetrix
Oligonucleotide Array (Affy) R package [9], uses
a model: T(PMij) = ei + aj + εij,i = 1,...,I ,j =
1,..., J, where T is the transformation that back-
ground corrects, normalizes, and logs the PM inten-
sities, ei is the log2 scale expression value found
on arrays i = 1,..., I and aj is the log scale afﬁn-
ity effects for probes j = 1,...,J. According to
Irizarry et al. [7], RMA has a better precision than
MAS and dCHIP, especially for low expression
values. Concerning the amount of true positives
identiﬁed using spiked-in experiments, RMA per-
forms slightly better than dCHIP, but much better
than MAS [7]. In our hands, dCHIP compresses
intensity signals with respect to MAS 5.0 measures
in the low expression values (Figure 1A). Instead,
RMA and MAS 5.0 detect intensity signals in a
similar manner, even in the low expression values
(Figure 1B). On the basis of published data and
our observations, RMA seems the best approach,
at present, to measure probe set expression levels,
as it shows better sensitivity and speciﬁcity with
respect to dCHIP and MAS.
Data normalization
Array experimental conditions can strongly affect
microarray hybridization intensities. It is assumed
that sources of error are multiplicative and strongly
affect true expression levels [6], especially if the
genes are moderately expressed [13]. Therefore,
normalization of gene expression data is a crucial
preprocessing procedure that is essential for nearly
all gene expression studies in which data from one
array must be compared to data on an other array.
A number of normalization approaches may be
taken into account [5,12], however, a gold standard
method for microarray data normalization has not
been deﬁned. Thus, the chosen method should be
motivated by the application at hand and the goals
of the data analysis.
MAS 5.0 performs a background correction
across the entire array and also offers the possibility
of performing data scaling, which is a mathematical
technique that can minimize discrepancies due to
variables such as sample preparation, hybridization
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Figure 1. Comparison between expression measures performed on the same data set (MGU74Av2) using MAS 5.0 (scaling
normalization), dCHIP 1.3 (invariant set normalization), and RMA (quantile normalization). (A) Expression measures
obtained with dCHIP are plotted vs. MAS. (B) Expression measures obtained with RMA are plotted vs. MAS
conditions, staining or probe array lot. The scal-
ing procedure does not affect the global similarity
between the samples (Figure 2A, B; r2 = 0.9331
for raw and scaled data).
The Invariant Set Normalization method is used
in dCHIP [10] to normalize arrays. In this normal-
ization procedure, an array with median overall
intensity is chosen as the baseline array against
which other arrays are normalized at probe inten-
sity level. Subsequently, a subset of PM probes,
with small within-subset rank difference in the two
arrays, serve as the basis for ﬁtting a normalization
curve. This normalization method produces a bet-
ter ﬁtting of the replicates with respect to the MAS
scaling procedure (Figure 2C; r2 = 0.9578).
The Affy R package implements three differ-
ent normalization procedures [3]: cyclic Loess,
contrast-based method and quantile normalization
(Figure 2D; r2 = 0.9540). According to Bolstad
[3], all the three methods reduce the variation of a
probe set measure across a set of arrays to a greater
extent than does the MAS 5.0 scaling method, and
the quantile method performs better in terms of
speed. The quantile method tries to make the same
the distribution of probe intensities for each array
in a set of arrays. The method is bound to the idea
that a quantile–quantile plot shows that the distri-
bution of two data vectors is the same if the plot
is a straight diagonal. Since this concept can be
extended to n dimensions, it is possible to make a
set of data have the same distribution if the points
of the n dimensional quantile plot are projected
onto the diagonal [3]. This projection implies that
it is possible to give the same distribution to each
array by taking the mean quantile and substituting it
as the value of the data item in the original data set.
As shown by the r2 correlation coefﬁcient in
Figure 2, dCHIP gives better correlation between
two replicates than the RMA/quantile normaliza-
tion. Both dCHIP and RMA/quantile normalization
perform better than MAS 5.0 scaling.
Filtering
In microarray analysis, the exclusion from the
dataset of non-informative probe sets, before get-
ting to the statistical validation of the differential
expression, is another step of the analysis. This
step can be achieved by performing various ﬁlter-
ing procedures [14]. The stringency of the ﬁlter-
ing procedure could strongly affect (in a positive
or a negative manner) the ﬁnal results, as it can
cause the loss of differentially expressed genes or
increase the number of false positives contaminat-
ing the ﬁnal results. In our lab, we remove from the
original data set all probe sets which show, within
all arrays, a signal very near to the background,
using the MAS 5.0 absent calls (call A) [14]. Fur-
thermore, we remove all probe sets showing low
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Figure 2. Comparison between various normalization methodologies. (A) Expression measures for two mouse breast
biological replicates (MGU74Av2) are plotted against each other, as raw data. (B) As (A) but scaled according to MAS
5.0. (C) As (A) but normalized according to dCHIP 1.3. (D) As (A) but normalized according to the RMA method (Affy
R package)
hybridization quality, using the probe set hybridiza-
tion quality standard errors (SE) generated by
dCHIP [14]. The intensity values obtained using
RMA/quantile normalization are subsequently cou-
pled to the ﬁltered genes and used for statistical
validation.
Statistical validation of differential
expression
Because microarray results are inﬂuenced by vari-
ous experimental errors [4] it is important to per-
form replicates of the experiments in order to assess
the variability of the gene expression levels in the
treatment and control groups and to evaluate the
statistical meaning of those variations. Statistical
validation is quite important because the simple-
minded fold approach, in which a gene is declared
to have signiﬁcantly changed if its average expres-
sion level varies by more than a constant factor,
is unlikely to yield optimal results because the
fold change factor can have different signiﬁcance,
depending on expression levels [2]. Usually, for a
limited number of replicates, a parametric or non-
parametric test can be carried out. When multiple
hypotheses are tested, as in the case of thousands
of genes present on a microarray, the probability
that at least one type I error (i.e. a gene is con-
sidered differentially expressed although it is not
true) is committed can increase sharply with the
number of hypotheses. For these reasons, a variety
of approaches have been developed to avoid this
kind of error.
Signiﬁcance analysis of microarrays (SAM) was
developed by Tusher and co-workers [16] and
is a statistical technique for ﬁnding genes show-
ing signiﬁcant differential expression in a set of
microarray experiments. The input to SAM is gene
expression measurements from a set of microar-
ray experiments, as well as a response variable
from each experiment. SAM measures the strength
of the relationship between gene expression and
the response variable and uses repeated permuta-
tions of the data to determine whether the expres-
sion of any gene is signiﬁcantly related to the
response. The user has to deﬁne the acceptable false
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discovery rate, and can also specify a fold change
threshold.
CyberT was developed by Baldi and Long [2]; it
allows the calculation of how meaningful a differ-
ential expression is using a Bayesian probabilistic
framework. In particular, CyberT uses a Bayesian
approach to calculate a background variance for
each of the genes under analysis and it uses such
values to balance experimental ﬂuctuations within
a limited number of replicates. As demonstrated
by the authors [2], the Bayesian approach appears
robust relative to the use of fold change alone, as
large non-statistically signiﬁcant fold changes are
often associated with large measurement errors. In
our lab, we use CyberT to validate results gener-
ated by SAM: we consider a gene differentially
expressed only if it has passed the SAM test and if
it is present within the top score results generated
by CyberT [14].
Conclusions
Although the methodologies described in this paper
are currently the most robust tools available and are
constantly updated by the developers, we have to
take into account that microarray analysis is a very
dynamic ﬁeld and many new tools are becoming
available. Therefore, it has to be accepted that,
in order to grasp all of the hidden knowledge in
our datasets, they must be analysed again as new
appealing methodologies emerge.
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